China Resources Double-Crane Pharmaceutical's (SHA:600062) net profit attributable to shareholders in the third quarter rose 6.7% year on year to 374 million yuan, according to a Shanghai bourse filing on Saturday.
The Chinese pharmaceutical company's shares rose over 1% during Monday morning trade.
Earnings per share in the same quarter increased 7.2% year on year to 0.36 yuan.
Operating revenue slipped 3% from a year earlier to 2.54 billion yuan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments